My Jonasson
Medical Physicist at Department of Surgical Sciences; Molecular imaging and medical physics
- E-mail:
- my.jonasson@uu.se
- Visiting address:
- Akademiska sjukhuset, ingång 70, 1tr
- Postal address:
- Akademiska sjukhuset, ingång 70, 1tr
751 85 UPPSALA
More information is available to staff who log in.
Research
This text is not available in English, therefore the Swedish version is shown.
Publications
Selection of publications
- Quantification of aromatase binding in the female human brain using [11 C]cetrozole positron emission tomography. (2020)
- Optimal timing of tau pathology imaging and automatic extraction of a reference region using dynamic [18F]THK5317 PET (2019)
- Towards Clinical Implementation of Dynamic Positron Emission Tomography in Neurodegenerative Diseases (2018)
- Development of a clinically feasible [11C]PE2I PET method for differential diagnosis of parkinsonism using reduced scan duration and automated reference region extraction. (2017)
- Tracer kinetic analysis of [C-11] Cetrozole as a PET tracer for aromatase in the human brain (2017)
- Tracer kinetic analysis of (S)-18F-THK5117 as a PET tracer for assessing tau pathology. (2016)
- Validation of parametric methods for [(11)C]PE2I positron emission tomography (2013)
Recent publications
- Acute nicotine exposure blocks aromatase in the limbic brain of healthy women (2023)
- Striatal dopamine transporter and receptor availability correlate with relative cerebral blood flow measured with [11C]PE2I, [18F]FE-PE2I and [11C]raclopride PET in healthy individuals (2023)
- Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy (2022)
- Expectancy effects on serotonin and dopamine transporters during SSRI treatment of social anxiety disorder (2021)
- Expression and co-expression of serotonin and dopamine transporters in social anxiety disorder (2021)
All publications
Articles
- Acute nicotine exposure blocks aromatase in the limbic brain of healthy women (2023)
- Striatal dopamine transporter and receptor availability correlate with relative cerebral blood flow measured with [11C]PE2I, [18F]FE-PE2I and [11C]raclopride PET in healthy individuals (2023)
- Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy (2022)
- Expectancy effects on serotonin and dopamine transporters during SSRI treatment of social anxiety disorder (2021)
- Expression and co-expression of serotonin and dopamine transporters in social anxiety disorder (2021)
- Quantification of aromatase binding in the female human brain using [11 C]cetrozole positron emission tomography. (2020)
- Optimal timing of tau pathology imaging and automatic extraction of a reference region using dynamic [18F]THK5317 PET (2019)
- Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia (2018)
- Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease. (2018)
- Differential diagnosis of patients with parkinsonian syndrome using multilinear regression to disease-specific C-11-PE2I-PET templates and classification tree learning (2018)
- Association between amygdala neurokinin-1 receptor availability and anxiety-related personality traits (2018)
- Quantitative positron emission tomography in brain research (2017)
- Development of a clinically feasible [11C]PE2I PET method for differential diagnosis of parkinsonism using reduced scan duration and automated reference region extraction. (2017)
- Tracer kinetic analysis of [C-11] Cetrozole as a PET tracer for aromatase in the human brain (2017)
- Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm (2016)
- Alterations in the serotonergic and substance P systems in posttraumatic stress disorder (2016)
- Reduced serotonin synthesis and regional cerebral blood flow after anxiolytic treatment of social anxiety disorder (2016)
- Overlapping expression of serotonin transporters and neurokinin-1 receptors in posttraumatic stress disorder (2016)
- Tracer kinetic analysis of (S)-18F-THK5117 as a PET tracer for assessing tau pathology. (2016)
- Use of C-11-PE2I PET in Differential Diagnosis of Parkinsonian Disorders (2015)
- Serotonin Synthesis and Reuptake in Social Anxiety Disorder (2015)
- Increased neurokinin-1 receptor availability in the amygdala in social anxiety disorder (2015)
- O-15-Water PET Study of the Effect of Imatinib, a Selective Platelet-Derived Growth Factor Receptor Inhibitor, Versus Anakinra, an IL-1R Antagonist, on Water-Perfusable Tissue Fraction in Colorectal Cancer Metastases (2015)
- Validation of parametric methods for [(11)C]PE2I positron emission tomography (2013)
- Effect of variations in cerebellum kinetics on robustness of [C-11]DASB parametric images (2012)
- Changes in serotonin and dopamine transporter availability after combined treatment with escitalopram and cognitive-behavioral therapy in patients with social anxiety disorder
- Response expectancies shape the effect of SSRI treatment on serotonin and dopamine transporters in patients with social anxiety disorder